AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹7,942 Cr |
| Mar2024 | ₹6,315 Cr |
| Mar2023 | ₹4,862 Cr |
| Mar2022 | ₹2,373 Cr |
| Mar2021 | ₹4,972 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,942 Cr | 25.75 | |
| Mar2024 | ₹6,315 Cr | 29.90 | |
| Mar2023 | ₹4,862 Cr | 104.89 | |
| Mar2022 | ₹2,373 Cr | -52.28 | |
| Mar2021 | ₹4,972 Cr | - | |
Compare Total Debt of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹76,302.6 Cr | 1.7% | 12.8% | 9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.7% |
12.8% |
9% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses